Contamination, FDA Compliance and Research - Clinical Research Informer

FDA End-of-Year Release of Warning Letters Impresses (or Depresses)

FDA Law Blog

JANUARY 1, 2024

The FDA compliance data, sorted by category, shows there were 159 Warning Letters issued to drug manufacturers or sponsors during 2023, with 161 issued in calendar year 2022. Finally, FDA said in a Warning Letter that a Clinical Investigator, Anish S. Dextrum Laboratories Inc. Shah, M.D.,

Manufacturing

Manufacturing Production Drugs Contract Manufacturing

Comprehensive Guide to Medical Device Safety, Systems, and Regulatory Compliance: FAQ

Cloudbyz

AUGUST 19, 2024

Facility Controls: Ensuring that manufacturing facilities are designed, maintained, and operated to prevent contamination, errors, and defects. Regulatory Approval: Obtaining approval from regulatory bodies, such as the FDA or EU regulatory authorities, before initiating the trial. requires FDA compliance and UDI labeling.

Compliance

Compliance Manufacturing Regulation Marketing

Clinical Research Informer

FDA End-of-Year Release of Warning Letters Impresses (or Depresses)

Comprehensive Guide to Medical Device Safety, Systems, and Regulatory Compliance: FAQ

Webinars

Stay Connected